Ind-Swift progressing with expansion plansIllustrative image – not actual.

Chandigarh-based pharmaceutical company Ind-Swift Ltd is progressing well with its Rs.100 crore expansion plan.

The company is setting up three units in Punjab, Himachal Pradesh and Jammu and Kashmir and expects the projects to be completed in about nine months.

The additional capacities include a 100 per cent export-oriented unit at Lalru (Punjab), a new finished dosage facility at Baddi (Himachal Pradesh) and a new unit at Samba (Jammu & Kashmir). The company expects the estimated three-fold expansion to result in a 40 per cent growth in sales and profits.

Funds are being raised through a recent preferential allotment, term loans and internal accruals.

The new unit at Jammu is nearing completion and is expected to commence production soon and the other two units are expected to be operational by September 2005. Further, the company has purchased land in Baddi for setting up a new formulation facility for the manufacture of oncology, cephalosporins, beta-lactum, herbal & neutraceutical products. The facility when operational will be largest in terms of capacity in north India, it is understood.

← All latest storiesBack to top →